Current neuropsychological, electrophysiological, and other imaging da
ta strongly suggest the existence of a neurobiological basis for obses
sive-compulsive disorder (OCD), which was long considered to be exclus
ively of psychogenic origin. The positive response of some OCD patient
s to neurosurgery, as well as the efficacy of agents that selectively
block serotonin reuptake, lends further support to a biological involv
ement. However, a survey of the treatment literature reveals that only
45-62% of OCD patients improve with these specific medications. In a
pilot study using a quantitative electroencephalographic (QEEG) method
known as neurometrics, in which QEEG data from OCD patients were comp
ared statistically with those from an age-appropriate normative popula
tion, we previously reported the existence of two subtypes of OCD pati
ents within a clinically homogeneous group of patients who met DSM-III
-R criteria for OCD. Following pharmacological treatment, a clear rela
tionship was found between treatment response and neurometric cluster
membership. In this study, we have expanded the OCD population, adding
patients from a second site, and have replicated the existence of two
clusters of patients in an enlarged, statistically more robust popula
tion. Cluster 1 was characterized by excess relative power in theta, e
specially in the frontal and frontotemporal regions; cluster 2 was cha
racterized by increased relative power in alpha. Further, 80.0% of the
members of cluster 1 were found to be nonresponders to drug treatment
, while 82.4% of the members of cluster 2 were found to be treatment r
esponders. These findings suggest the existence of at least two pathop
hysiological subgroups within the OCD population that share a common c
linical expression, but show a differential response to treatment with
serotonin reuptake inhibitors.